Financial Data and Key Metrics Changes - The company reported a revenue increase of approximately 10% for the upcoming year, with an overall revenue growth projection of 11% [2] - The revenue from electric tools is expected to double this year, reaching around 20 billion, with projections of approximately 34 billion next year, indicating a growth rate of over 70% [3][4] - The company anticipates maintaining a revenue growth contribution of around 10% annually over the next few years [3] Business Line Data and Key Metrics Changes - The company plans to categorize its products into three main categories: hand tools, industrial equipment, and electric tools, with electric tools currently accounting for 8% of total revenue [1][2] - The introduction of 20-volt electric tools marks a significant shift from the previous 12-volt offerings, expanding the market potential to over 20 billion [4][5] - The electric tools segment is expected to see substantial growth due to new orders and expanded product lines, with a projected order volume of 300 million to 300 million USD next year [6][7] Market Data and Key Metrics Changes - The market for 20-volt electric tools is estimated to be around 10 billion USD, with the potential to exceed 20 billion USD as the company expands its offerings [5] - The company has secured significant orders from major retailers, contributing to its rapid growth in the electric tools market [7] Company Strategy and Development Direction - The company is focusing on expanding its product categories and distribution channels to enhance market penetration in the electric tools segment [10][11] - There is a clear strategy to improve valuation by demonstrating growth in the electric tools market, which has historically been underrepresented [10][11] Management Comments on Operating Environment and Future Outlook - Management expressed optimism about the recovery of the market, particularly in the electric tools segment, driven by a rebound in the real estate sector and overall economic conditions [12] - The company expects to adjust its earnings forecast upwards by 100 to 200 million due to accelerated capacity expansion and strong growth in electric tools [13] Other Important Information - The company has been recognized for its technological advancements in electric tools, which are expected to lead to a higher valuation compared to historical averages [10][11] - The company is positioned as a strong investment opportunity, with a stable performance record over recent years [12] Q&A Session Summary Question: Is the company's second-quarter performance above expectations? - Management confirmed that the performance exceeded expectations and indicated that an upward adjustment of 100 to 200 million is reasonable due to significant changes in capacity and product growth [13]

Financial Data and Key Metrics Changes - The company is facing pressure due to inventory reduction in the industry, but the actual terminal demand has not decreased, indicating potential for future growth once inventory levels stabilize [12][57][60] - The company aims for a profit target of over 1 billion this year, contingent on inventory management and market conditions [55][57] Business Line Data and Key Metrics Changes - The company has a dedicated team of 500 people for the promotion of its new product, indicating strong resource allocation for market penetration [3] - The sales of the quadrivalent vaccine are stable, with expectations for a potential increase in demand due to changes in immunization schedules [31][32] Market Data and Key Metrics Changes - The company has signed contracts with over a dozen countries for vaccine exports, particularly in Southeast Asia, South Asia, North Africa, and South America, indicating significant market expansion potential [4][17] - The penetration rate for the 13-valent vaccine in the domestic market has reached approximately 30%, with expectations for slower growth as it approaches higher penetration levels [14][15] Company Strategy and Development Direction - The company is focusing on market education rather than aggressive sales tactics in the current regulatory environment, which is seen as a more sustainable approach [2] - The company is exploring partnerships with major pharmaceutical firms to enhance its market presence and expedite entry into new markets [44][61] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term demand for vaccines despite current inventory pressures, emphasizing the importance of maintaining consumer trust in the vaccine market [12][60] - The company anticipates that the adult vaccine market in China has significant untapped potential, which could provide growth opportunities in the future [63] Other Important Information - The company is preparing for potential product price adjustments in response to market dynamics, but it believes its diverse product lineup mitigates risks associated with price competition [36][38] - The company is actively working on regulatory approvals and local partnerships to facilitate faster market entry for its vaccines [6][61] Q&A Session Summary Question: What is the current status of the diploid vaccine sales and terminal sales performance? - The company indicated that the sales data for June is not yet available, but it expects the performance to align with inventory levels in the market [9] Question: Will the company adjust the price of convertible bonds based on stock performance? - Management stated that the decision regarding convertible bonds will depend on market conditions and will be announced on July 4 [10] Question: How does the company view competition in the 13-valent vaccine market? - The company believes it has a competitive edge due to its pricing and product quality, despite new entrants in the market [15][17] Question: What are the expectations for the 13-valent vaccine's sales in overseas markets? - Management expressed that while significant sales growth in the short term is challenging, they expect gradual increases over the next few years [18] Question: How is the company addressing the impact of price reductions in the vaccine market? - The company noted that not all products are affected by price reductions, and it has strategically priced its offerings to maintain competitiveness [36][38] Question: What is the company's outlook for the hepatitis B vaccine market? - The company anticipates stable growth in the hepatitis B vaccine segment, with ongoing efforts to capture a larger market share [49][50]

Financial Data and Key Metrics Changes - The company has approximately 6 billion RMB in self-owned funds, along with a bank credit line totaling about 30 billion RMB, which supports liquidity needs and debt repayment risks [2] - The current pledge rate is around 50%, indicating that risks are manageable [2] Business Line Data and Key Metrics Changes - The ODM business reported a loss of approximately 350 million RMB in Q1, primarily due to low order prices, rising raw material costs, and high labor wages [4][9] - The semiconductor business experienced a slight decline in revenue and gross margin in Q1, but market demand improved in Q2, leading to expectations of revenue and margin recovery [10][11] Market Data and Key Metrics Changes - The power semiconductor market demand has shown slight improvement, with the consumer electronics and automotive markets gradually recovering, which is expected to drive the company's semiconductor business growth [7][22] Company Strategy and Development Direction - The company plans to invest 200 million USD in expanding production lines for potassium nitride and silicon carbide at its Hamburg plant, with a focus on upgrading from a 6-inch to an 8-inch production line [1][3] - The company aims to optimize its product structure to drive future growth, particularly in the electric vehicle sector, where it collaborates with major domestic brands [15][17] Management Comments on Operating Environment and Future Outlook - Management noted that while there has been some recovery in demand in Q2, it is not significantly pronounced, and future industry demand is not expected to show double-digit growth [11] - The company is focused on reducing manufacturing costs and improving factory utilization rates to enhance overall performance [10][12] Other Important Information - The company is currently conducting automotive qualification tests at its Lingang wafer factory, with a planned capacity of 30,000 wafers per month by the end of the year [3][6] - The company is also developing new products, including IGBT, silicon carbide, and silicon nitride, to enhance its competitive position in the market [14][19] Q&A Session Summary Question: What are the details of the recent 200 million USD expansion plan? - The expansion plan involves building production lines for potassium nitride and silicon carbide at the Hamburg plant, currently in the planning stage [3] Question: What is the current capacity situation for silicon carbide and potassium nitride? - The current production is mainly experimental or small-scale, with plans to upgrade to an 8-inch line [4] Question: How is the company's ODM business performing? - The ODM business faced a loss of 350 million RMB in Q1 due to low order prices and rising costs, with efforts underway to adjust pricing [9] Question: What is the outlook for the semiconductor business in Q2? - The semiconductor business is expected to see improvements in revenue and gross margin due to recovering market demand [10] Question: What is the company's market position in the electric vehicle sector? - The company collaborates with major domestic brands and aims to enhance its product offerings in the electric vehicle market [18]

| --- | --- | |------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

更多资料加入知识星球：水木调研纪要 关注公众号：水木纪要 [Table_Page] 投资策略|中期报告 2024年6月30日 证券研究报告 [中Table_国Title] 资产 ROE 如何实现层级跃迁 ——2024 年中期策略 [分Ta析ble师_A：uth or]刘 晨明 [Table_Summary] SAC 执证号：S0260524020001 报告摘要： liuchenming@gf.com.cn ⚫ 中国资产ROE如何实现层级跃迁。全球长时序的经验显示，高且稳定 分析师： 郑恺 的 ROE 对于资产回报率有着决定性作用，而目前中国与日韩国家的 SAC 执证号：S0260515090004 ROE普遍落在6%-8%（对应PB1-1.5倍）的低区。参考美、日、德经 SFC CE No. BUU989 验，龙头公司能够实现高且稳定ROE的两个条件：①反内卷，②全球 zhengkai@gf.com.cn 化。虽然很难，但这似乎是部分中国资产未来实现ROE层级跃迁的必 分析师： 余可骋 经之路，在总需求缺乏大的β的背景条件下，也将对应着下一个时代的 SAC 执证号：S0260524030007 核心资产。 ...

证券研究报告 拐点临近，景气上行 ——国防军工行业2024半年度策略 行业评级：看好 2024年6月23日 ...

[Table_Main] 公司研究|可选消费|汽车与汽车零部件 证券研究报告 比亚迪(002594)公司首次覆盖报 2024年06月23日 告 [Table新_Tit能le]源 车领军企业，剑指海外市场 [Table 买_Inv 入est] | 首次推荐 ——比亚迪(002594)首次覆盖报告 [报Ta告bl要e_S点um：ma ry] [当T前ab价le/_目Ta标r价ge：tP 2r5i0c.e6]7 元/315.90元  公司是国内新能源车领军企业，产能渠道布局领先 目标期限： 6个月 公司成立于1995年，凭借多年的技术革新和生产实践，公司已经构建了从 [基T本ab数le据_B ase] 上游电池原材料、IGBT、SiC等关键组件，到中游新能源三电系统、混合动 52周最高/最低价(元)： 272.0 / 167.0 力平台、整车电子、底盘、内饰等核心部件，再到下游汽车销售及金融服务 A股流通股(百万股)： 2260.47 等全产业链的深度研发与精细成本控制能力。产能方面，公司目前国内合 A股总股本(百万股)： 2909.27 计规划产能已达 475 万辆，海外合计规划产能已达 110 万辆。渠道布局 ...

2024 年 06 月 25 日 宏观深度研究 研究所： [Table_Title] 寻找房价周期之锚 证券分析师： 夏磊 S0350521090004 xial@ghzq.com.cn ——一个日本视角 最近一年走势 房地产如此重要，关系国计民生，它是国民经济的支柱、财富的象 征、大类资产配置的核心、经济周期之母、民生的保障、金融危机 的策源地。 房价是反映房地产市场波动的核心指标之一，其变动影响购房者预 期、居民家庭财富变动和金融体系的稳定。 近年来，房价波动引发广泛讨论，市场开始寻求其变化规律，试图 找到能判断房价是否见底的“锚”。我们从周期视角、收益率视角、 收入视角、货币视角，分析判断房价变动趋势及其内在逻辑。本文 相关报告 是该系列研究的第一篇：周期之锚。 《开年看地产：一线城市房地产市场怎么走》—— 2024-03-19 从1998年房改以来，中国的房价经历了二十多年的平稳上升，并未 《构建“人房地钱”联动的房地产发展新模式*夏磊》 经历大幅调整。国际来看，发达国家的房价经历过明显的周期，特 ——2024-03-05 别是日本，在基本面上和中国有相似之处，也有一定的差异。 《2024年房地产市场 ...

行 业 研 究 2024.06.20 电 子 行 业 专 题 报 告 模拟芯片库存拐点已至，AI 拉动电源相关需求 方 正 证 券 研 究 所 证 券 研 究 报 告 分析师 原厂+渠道携手控制库存，拐点已至。库存方面，本轮周期下行期中，模拟 郑震湘 登记编号：S1220523080004 芯片原厂携手分销商、汽车Tier 1厂商一同控制库存，已取得一定成效。 TI表示国内工业库存去化已经接近尾声；ADI本季度库存去化近1亿美元， 佘凌星 登记编号：S1220523070005 预期下季度库存将进一步优化；瑞萨表示渠道长期库存已经趋于稳定；NXP 的分销渠道库存成效显著，已控制在 1.6 个月。我们认为随着下游需求逐 步复苏，模拟芯片库存将趋于正常。 行 业 评 级 :推 荐 工业需求强劲复苏，AI芯片功率提升拉动电源相关需求。需求方面，ADI表 行 业 信 息 示强劲的PMI数据支撑了工业领域持续的订单，这有助于库存的不断消化， 上市公司总家数 511 工业行业将于下个季度重回增长。MPS看到了 AI 需求强劲，在积极备货主 总股本(亿股) 5,485.32 动增加库存。算力芯片功率相较于传统 CPU 高出 ...

证券研究报告 风格决定胜负，科技成长崛起 ——2024年下半年A股策略展望 ...